Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

GNW earnings analysis

Filed May 6, 2026 · Our reading of the company's report

The latest report

Genworth Financial reported Q1 2026 results with increased total revenue of $1.78B and EPS of $0.28, both exceeding expectations. The Enact segment showed strong growth with a 30% increase in new insurance written,…

Read full summary

Genworth Financial reported Q1 2026 results with increased total revenue of $1.78B and EPS of $0.28, both exceeding expectations. The Enact segment showed strong growth with a 30% increase in new insurance written, while overall operating income fell slightly compared to the previous year. The balance sheet showed a reduction in cash and a marginal increase in assets, underscoring ongoing strategic investments in CareScout services.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

33% Gross margin Operating margin Feb 2025 Nov 2025

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Feb 2024 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$0.28
Segment
Enact
Segment
Closed Block

What stood out

  • Revenue Growth

    Total revenue for Q1 2026 was $1.78B, a slight decrease from $1.79B in Q4 2025, driven primarily by favorable Enact segment performance.

  • Positive EPS Surprise

    EPS for Q1 2026 was $0.28, exceeding the estimated $0.20.

  • Strong Enact Growth

    New insurance written increased 30% year-over-year to $12.79B in Q1 2026.

  • Increased Net Investment Income

    Net investment income rose to $766M, up 4% from Q1 2025.

  • Share Repurchase Program

    Genworth Financial repurchased $66M of its shares in Q1 2026, maintaining shareholder value.

  • Stable Risk-to-Capital Ratio

    Enact's risk-to-capital ratio improved to 10.0:1, well below the maximum threshold.

What to watch

  • Lower Operating Income

    Operating income decreased to $80M in Q1 2026 from $90M in Q1 2025, mainly due to increased claim expenses.

  • Investment Losses

    Net investment losses for Q1 2026 were reported at $(26)M, significantly down from gains of $27M in Q1 2025.

  • Regulatory Headwinds

    Changes in PMIERs could impact capital sufficiency in Enact's future operational performance.

Management's outlook

Outlook deferred to earnings press release / call.

Earlier filings 4

10-K · February 27, 2026

Genworth repositioned around two reportable segments (Enact and Closed Block) and is investing in CareScout while returning capital to shareholders: Enact returned $407 million to Genworth Holdings in 2025 and the…

10-Q · November 6, 2025

Genworth reported Q3 2025 total revenues of $1,935 million, up $55 million (from $1,880 million) year-over-year, with income from continuing operations before income taxes of $164 million. Net income available to common…

10-Q · July 31, 2025

Genworth reported quarterly revenues of $1,796 million (up $27 million vs Q2 2024) while income from continuing operations fell to $90 million (versus $111 million in Q2 2024), driving net income to $83 million (vs $110…

10-Q · May 2, 2025

Genworth reported Q1 2025 total revenues of $1,786 million, down $78 million (−4.2%) from $1,864 million in Q1 2024, and diluted EPS to common shareholders declined to $0.13 (from $0.31). Operating profitability…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.